Evaluation of Toxicity
| Patient No. . | Courses . | Neutropenia (grade III-IV) . | G-CSF (courses) . | Anemia (grade III-IV) . | RBC (U) . | Other (grade) . |
|---|---|---|---|---|---|---|
| 1 | 3 | 1/3 | 0/3 | 1/3 | 2 | — |
| 2 | 3 | 1/3 | 0/3 | 1/3 | 2 | — |
| 3 | 1 | 1/1 | 0/1 | 1/1 | 1 | — |
| 4 | 3 | 1/3 | 2/3 | 2/3 | 4 | — |
| 5 | 3 | 3/3 | 0/3 | 0/3 | 0 | — |
| 6 | 3 | 3/3 | 0/3 | 1/3 | 2 | — |
| 7 | 3 | 1/3 | 0/3 | 0/3 | 0 | — |
| 8 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 9 | 3 | 1/3 | 2/3 | 0/3 | 0 | — |
| 10 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 11 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 12 | 3 + 3 | 0/6 | 5/6 | 1/6 | 1 | — |
| 13 | 1 | 1/1 | 1/1 | 0/1 | 0 | — |
| 14 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | Nausea (II), headache (I) |
| 15 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 16 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | Herpes vaginalis (II) |
| 17 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 18 | 3 + 3 | 2/6 | 6/6 | 1/6 | 3 | — |
| 19 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 20 | 3 | 1/3 | 2/3 | 1/3 | 2 | — |
| 21 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 22 | 3 + 2 | 0/5 | 4/5 | 0/5 | 0 | Peripheral neuropathy (III) |
| 23 | 3 | 2/3 | 2/3 | 0/3 | 0 | — |
| 24 | 3 | 2/3 | 2/3 | 2/3 | 4 | — |
| 25 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 26 | 3 + 3 | 2/6 | 5/6 | 0/6 | 0 | — |
| 27 | 3 + 3 | 1/6 | 5/6 | 0/6 | 0 | Nausea (II) |
| 28 | 1 | 0/1 | 0/1 | 0/1 | 0 | Septic shock (IV) |
| 29 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| Total courses | 119 | 23 (19%) | 82 (69%) | 11 (9%) | 21 units | |
| Total patients | 29 | 15 (52%) | 22 (76%) | 9 (31%) | 9 (31%) |
| Patient No. . | Courses . | Neutropenia (grade III-IV) . | G-CSF (courses) . | Anemia (grade III-IV) . | RBC (U) . | Other (grade) . |
|---|---|---|---|---|---|---|
| 1 | 3 | 1/3 | 0/3 | 1/3 | 2 | — |
| 2 | 3 | 1/3 | 0/3 | 1/3 | 2 | — |
| 3 | 1 | 1/1 | 0/1 | 1/1 | 1 | — |
| 4 | 3 | 1/3 | 2/3 | 2/3 | 4 | — |
| 5 | 3 | 3/3 | 0/3 | 0/3 | 0 | — |
| 6 | 3 | 3/3 | 0/3 | 1/3 | 2 | — |
| 7 | 3 | 1/3 | 0/3 | 0/3 | 0 | — |
| 8 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 9 | 3 | 1/3 | 2/3 | 0/3 | 0 | — |
| 10 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 11 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 12 | 3 + 3 | 0/6 | 5/6 | 1/6 | 1 | — |
| 13 | 1 | 1/1 | 1/1 | 0/1 | 0 | — |
| 14 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | Nausea (II), headache (I) |
| 15 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 16 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | Herpes vaginalis (II) |
| 17 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 18 | 3 + 3 | 2/6 | 6/6 | 1/6 | 3 | — |
| 19 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 20 | 3 | 1/3 | 2/3 | 1/3 | 2 | — |
| 21 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| 22 | 3 + 2 | 0/5 | 4/5 | 0/5 | 0 | Peripheral neuropathy (III) |
| 23 | 3 | 2/3 | 2/3 | 0/3 | 0 | — |
| 24 | 3 | 2/3 | 2/3 | 2/3 | 4 | — |
| 25 | 3 | 0/3 | 2/3 | 0/3 | 0 | — |
| 26 | 3 + 3 | 2/6 | 5/6 | 0/6 | 0 | — |
| 27 | 3 + 3 | 1/6 | 5/6 | 0/6 | 0 | Nausea (II) |
| 28 | 1 | 0/1 | 0/1 | 0/1 | 0 | Septic shock (IV) |
| 29 | 3 + 3 | 0/6 | 5/6 | 0/6 | 0 | — |
| Total courses | 119 | 23 (19%) | 82 (69%) | 11 (9%) | 21 units | |
| Total patients | 29 | 15 (52%) | 22 (76%) | 9 (31%) | 9 (31%) |